Kalaris Therapeutics, Inc. (KLRS) shareholders
Close on Nov 17, 2026Market cap $34.04MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Srinivas Akkaraju Joint filing with Samsara BioCapital GP, LLC (44.90%), Samsara BioCapital, L.P. (44.80%) and 2 more | 12,900,583 | 54.20% | 13D (active) amendment | May 20, 2026 |
| Samsara BioCapital GP, LLC Joint filing with Samsara BioCapital, L.P. (61.20%), Srinivas Akkaraju (61.20%) | 11,448,081 | 61.20% | 13D (active) | Mar 18, 2025 |
| Ting Jia Joint filing with Octagon Capital Advisors LP (9.70%), Octagon Investments Master Fund LP (9.70%) | 11,202,000 | 9.70% | 13G (passive) | Sep 30, 2024 |
| Invus Public Equities, L.P. Joint filing with Invus Public Equities Advisors, LLC (5.80%), Artal International S.C.A (5.80%) and 5 more | 6,597,167 | 5.80% | 13G (passive) amendment | Dec 31, 2023 |
| Matthew D. Perry Joint filing with Coastlands Capital LP (5.69%), Coastlands Capital Partners LP (5.69%) and 2 more | 1,355,119 | 5.69% | 13G (passive) | Oct 19, 2026 |
| Roderick Wong Joint filing with RTW Investments, LP (5.70%) | 1,300,000 | 5.70% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of KLRS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 12,881,175 | 54.11% | $52.43M | −66,906 | 4.31% |
| Rtw Investments, LP | 1,300,000 | 5.46% | $5.29M | – | 0.05% |
| Alyeska Investment Group, L.P. | 572,687 | 2.41% | $2.33M | – | 0.01% |
| Siren, L.L.C. | 435,798 | 1.83% | $1.77M | – | 0.04% |
| Vanguard Capital Management LLC | 398,712 | 1.67% | $1.62M | +143,364 | 0.00% |
| Ikarian Capital, LLC | 360,000 | 1.51% | $1.47M | – | 0.16% |
| UBS Group AG | 262,131 | 1.10% | $1.07M | +255,947 | 0.00% |
| Renaissance Technologies LLC | 149,351 | 0.63% | $607.86K | +83,200 | 0.00% |
| Marshall Wace, Llp | 139,201 | 0.58% | $566.55K | +71,322 | 0.00% |
| Geode Capital Management, LLC | 114,037 | 0.48% | $464.29K | +26,492 | 0.00% |
| Woodline Partners LP | 100,000 | 0.42% | $407.00K | – | 0.00% |
| ADAR1 Capital Management, LLC | 100,000 | 0.42% | $407.00K | – | 0.02% |
| WHI TRUST Co LLC | 97,493 | 0.41% | $396.80K | – | 0.26% |
| Raymond James Financial Inc | 97,164 | 0.41% | $395.46K | −21,723 | 0.00% |
| Citadel Advisors LLC | 95,772 | 0.40% | $389.79K | New | 0.00% |
| Boothbay Fund Management, LLC | 92,261 | 0.39% | $375.50K | – | 0.00% |
| Verdad Advisers, LP | 80,297 | 0.34% | $326.81K | New | 0.31% |
| Morgan Stanley | 72,326 | 0.30% | $294.37K | +33,982 | 0.00% |
| Vanguard Fiduciary Trust Co | 66,179 | 0.28% | $269.35K | +29,462 | 0.00% |
| BlackRock, Inc. | 54,442 | 0.23% | $221.58K | +18,399 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 57 | 18M | 75.8% | 10 / 18 | 9 / 11 | 1M | 2M |
| Q1 2026 | 58 | 19M | 78.6% | 15 / 17 | 7 / 7 | 1M | 0M |
| Q4 2025 | 51 | 18M | 75.7% | 24 / 11 | 8 / 5 | 5M | 1M |
| Q3 2025 | 32 | 13M | 55.5% | 8 / 10 | 6 / 6 | 1M | 1M |
| Q2 2025 | 30 | 13M | 56.1% | 4 / 9 | 7 / 6 | 0M | 1M |
| Q1 2025 | 32 | 14M | 58.3% | 32 / 0 | 0 / 0 | 14M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
15 funds held KLRS in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of KLRS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 255,337 | 1.07% | $1.04M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 137,373 | 0.58% | $559.11K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 34,574 | 0.15% | $182.20K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 32,500 | 0.14% | $132.28K | 0.09% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 25,924 | 0.11% | $105.51K | 0.01% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 16,829 | 0.07% | $88.69K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 9,885 | 0.04% | $52.09K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 9,575 | 0.04% | $50.46K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 8,020 | 0.03% | $32.64K | 0.00% | Jun 30, 2026 |
| VIP Disciplined Small Cap Portfolio | 7,806 | 0.03% | $31.77K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 6,002 | 0.03% | $24.43K | 0.00% | Jun 30, 2026 |
| Dimensional US Core Equity 1 ETF | 3,296 | 0.01% | $11.57K | 0.00% | Jul 31, 2026 |
| U.S. Vector Equity Portfolio | 2,750 | 0.01% | $9.65K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 2,614 | 0.01% | $9.18K | 0.00% | Jul 31, 2026 |
| 1290 VT Micro Cap Portfolio | 1,725 | 0.01% | $7.02K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andrew Oxtoby | See Remarks, Director | – | – | Mar 20, 2026 |
| Vikas Sinha | See Remarks, Director, 10% owner | 774,118 | 3.25% | Feb 24, 2025 |
| Diana Brainard | Chief Executive Officer, Director | 723,363 | 3.04% | Nov 20, 2024 |
| Amy O'Leary Vandekop | VP, Corporate Controller | 948 | 0.00% | Aug 28, 2026 |
| Liisa Ann Bayko | Chief Financial Officer | – | – | Jul 20, 2026 |
| Brett R. Hagen | Chief Accounting Officer | 0 | – | Mar 23, 2026 |
| Matthew Gall | Chief Financial Officer | – | – | Mar 20, 2026 |
| Matthew Feinsod | Chief Medical Officer | 4,030 | 0.02% | Mar 20, 2026 |
| Edward Miller | General Counsel | 21,575 | 0.09% | Feb 24, 2025 |
| Laurie Keating | Director | – | – | Aug 3, 2026 |
| Leone D. Patterson | Director | – | – | Jun 4, 2026 |
| Morana Jovan-Embiricos | Director | 26,603,054 | 111.75% | Jun 4, 2026 |
| Napoleone Ferrara | Director | 504,000 | 2.12% | Jun 4, 2026 |
| Anthony P. Adamis | Director | – | – | Jun 4, 2026 |
| Srinivas Akkaraju | Director | 12,948,081 | 54.39% | Jun 4, 2026 |
| David Hallal | Director | 19,677,546 | 82.66% | Jun 4, 2026 |
| Michael Dybbs | Director | – | – | Jun 4, 2026 |
| Samir Chandrakant Patel | Director | 352,800 | 1.48% | Apr 11, 2025 |
| Samsara Opportunity Fund, L.P. | 10% owner | 12,948,081 | 54.39% | May 22, 2026 |
| Samsara BioCapital, L.P. | 10% owner | 12,915,520 | 54.26% | May 22, 2026 |
| Samsara Opportunity Fund GP, LLC | 10% owner | – | – | May 22, 2026 |
| Samsara BioCapital GP, LLC | 10% owner | 11,448,081 | 48.09% | May 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. 10% owner | May 20, 2026 | Other | +14,937 | – | – | 14,937 |
| Samsara BioCapital, L.P. 10% owner | May 20, 2026 | Buy | +244,300 | $4.83 | $1.18M | 2,224,147 |
| Samsara BioCapital, L.P. 10% owner | May 20, 2026 | Other | −66,906 | – | – | 10,657,028 |
| Samsara BioCapital, L.P. 10% owner | May 20, 2026 | Other | +4,471 | – | – | 19,408 |
| Brett R. Hagen Chief Accounting Officer | Mar 20, 2026 | Sale | −1,915 | $6.72 | $12.87K | 0 |
| Srinivas Akkaraju Director, 10% owner | Dec 22, 2025 | Award | +1,500,000 | $10.00 | $15.00M | 1,500,000 |
| Samsara Opportunity Fund, L.P. 10% owner | Dec 18, 2025 | Buy | +479,847 | $10.42 | $5.00M | 1,979,847 |
| Brett R. Hagen Chief Accounting Officer | Mar 26, 2025 | Sale | −907 | $8.97 | $8.14K | 1,925 |
| Napoleone Ferrara Director | Mar 18, 2025 | Award | +504,000 | – | – | 504,000 |
| Samir Chandrakant Patel Director | Mar 18, 2025 | Award | +252,000 | – | – | 252,000 |
| Samir Chandrakant Patel Director | Mar 18, 2025 | Award | +100,800 | – | – | 100,800 |
| Matthew Feinsod Chief Medical Officer | Mar 18, 2025 | Award | +4,030 | – | – | 4,030 |
| Srinivas Akkaraju Director, 10% owner | Mar 18, 2025 | Award | +11,444,503 | – | – | 11,444,503 |
| Brett R. Hagen Chief Accounting Officer | Feb 21, 2025 | Sale | −96 | $10.08 | $968 | 2,832 |
| Vikas Sinha See Remarks, Director, 10% owner | Feb 21, 2025 | Sale | −303 | $10.08 | $3.05K | 49,129 |
| Edward Miller General Counsel | Feb 21, 2025 | Sale | −106 | $10.08 | $1.07K | 6,517 |
| Vikas Sinha See Remarks, Director, 10% owner | Jan 23, 2025 | Sale | −116 | $9.45 | $1.10K | 49,445 |
| Vikas Sinha See Remarks, Director, 10% owner | Jan 23, 2025 | Sale | −13 | $9.94 | $129 | 49,432 |
| Brett R. Hagen Chief Accounting Officer | Jan 23, 2025 | Sale | −32 | $9.45 | $302 | 2,932 |
| Brett R. Hagen Chief Accounting Officer | Jan 23, 2025 | Sale | −4 | $9.94 | $40 | 2,928 |
| Edward Miller General Counsel | Jan 23, 2025 | Sale | −5 | $9.94 | $50 | 6,623 |
| Edward Miller General Counsel | Jan 23, 2025 | Sale | −47 | $9.45 | $444 | 6,628 |
| Vikas Sinha See Remarks, Director, 10% owner | Jan 10, 2025 | Sale | −979 | $0.44 | $431 | 1,139,915 |
| Edward Miller General Counsel | Jan 10, 2025 | Sale | −409 | $0.44 | $180 | 153,541 |
| Brett R. Hagen Chief Accounting Officer | Jan 10, 2025 | Sale | −332 | $0.44 | $146 | 68,174 |
| Edward Miller General Counsel | Dec 11, 2024 | Gift | −57,549 | – | – | 153,950 |
| Edward Miller General Counsel | Dec 11, 2024 | Gift | +57,549 | – | – | 346,348 |
| Diana Brainard Chief Executive Officer, Director | Nov 19, 2024 | Sale | −8,706 | $0.55 | $4.79K | 723,363 |
| Brett R. Hagen Chief Accounting Officer | Nov 19, 2024 | Sale | −554 | $0.55 | $305 | 68,506 |
| Vikas Sinha See Remarks, Director, 10% owner | Nov 19, 2024 | Sale | −3,186 | $0.55 | $1.75K | 1,140,894 |
| Edward Miller General Counsel | Nov 19, 2024 | Sale | −432 | $0.55 | $238 | 211,499 |
| Vikas Sinha See Remarks, Director, 10% owner | Nov 5, 2024 | Sale | −5,136 | $0.86 | $4.42K | 1,144,080 |
| Brett R. Hagen Chief Accounting Officer | Nov 5, 2024 | Sale | −1,655 | $0.86 | $1.42K | 69,060 |
| Edward Miller General Counsel | Nov 5, 2024 | Sale | −2,272 | $0.86 | $1.95K | 211,931 |
| Diana Brainard Chief Executive Officer, Director | Nov 5, 2024 | Sale | −10,609 | $0.86 | $9.12K | 732,069 |
| Vikas Sinha See Remarks, Director, 10% owner | Oct 22, 2024 | Sale | −1,882 | $0.77 | $1.45K | 1,149,216 |
| Edward Miller General Counsel | Oct 22, 2024 | Sale | −766 | $0.77 | $590 | 214,203 |
| Brett R. Hagen Chief Accounting Officer | Oct 22, 2024 | Sale | −486 | $0.77 | $374 | 70,715 |
| Diana Brainard Chief Executive Officer, Director | Oct 21, 2024 | Sale | −9,752 | $0.78 | $7.61K | 742,678 |
| Vikas Sinha See Remarks, Director, 10% owner | Oct 21, 2024 | Sale | −1,546 | $0.78 | $1.21K | 1,151,098 |
| Edward Miller General Counsel | Oct 21, 2024 | Sale | −635 | $0.78 | $495 | 214,969 |
| Brett R. Hagen Chief Accounting Officer | Oct 21, 2024 | Sale | −479 | $0.78 | $374 | 71,201 |
| Diana Brainard Chief Executive Officer, Director | Oct 3, 2024 | Sale | −1,493 | $0.81 | $1.21K | 752,430 |
| Brett R. Hagen Chief Accounting Officer | Oct 3, 2024 | Sale | −301 | $0.81 | $244 | 71,680 |
| Edward Miller General Counsel | Oct 3, 2024 | Sale | −377 | $0.81 | $305 | 215,604 |
| Vikas Sinha See Remarks, Director, 10% owner | Oct 3, 2024 | Sale | −940 | $0.81 | $761 | 1,152,644 |
| Diana Brainard Chief Executive Officer, Director | Aug 20, 2024 | Sale | −5,390 | $0.74 | $3.99K | 753,923 |
| Brett R. Hagen Chief Accounting Officer | Aug 19, 2024 | Sale | −544 | $0.76 | $413 | 71,981 |
| Edward Miller General Counsel | Aug 19, 2024 | Sale | −422 | $0.76 | $321 | 215,981 |
| Vikas Sinha See Remarks, Director, 10% owner | Aug 19, 2024 | Sale | −3,159 | $0.76 | $2.40K | 1,153,584 |
| Diana Brainard Chief Executive Officer, Director | Aug 19, 2024 | Sale | −3,091 | $0.76 | $2.35K | 759,313 |
| Brett R. Hagen Chief Accounting Officer | Aug 5, 2024 | Sale | −1,692 | $0.73 | $1.24K | 72,525 |
| Vikas Sinha See Remarks, Director, 10% owner | Aug 5, 2024 | Sale | −5,251 | $0.73 | $3.83K | 1,156,743 |
| Edward Miller General Counsel | Aug 5, 2024 | Sale | −2,323 | $0.73 | $1.70K | 216,403 |
| Diana Brainard Chief Executive Officer, Director | Aug 5, 2024 | Sale | −10,847 | $0.73 | $7.92K | 762,404 |
| Edward Miller General Counsel | Jul 22, 2024 | Sale | −757 | $0.74 | $560 | 218,726 |
| Vikas Sinha See Remarks, Director, 10% owner | Jul 22, 2024 | Sale | −1,858 | $0.74 | $1.37K | 1,161,994 |
| Brett R. Hagen Chief Accounting Officer | Jul 22, 2024 | Sale | −481 | $0.74 | $356 | 74,217 |
| Edward Miller General Counsel | Jul 19, 2024 | Sale | −634 | $0.75 | $476 | 219,483 |
| Diana Brainard Chief Executive Officer, Director | Jul 19, 2024 | Sale | −9,731 | $0.75 | $7.30K | 773,251 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kalaris Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 17,820 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Brett R. Hagen Officer | Mar 20, 2026 | 1,915 | $12.87K | Mar 20, 2026 | Restricted stock vesting under a registered plan |
| Edward Miller Officer | Feb 24, 2025 | 289 | $1.07K | Feb 21, 2025 | Restricted Stock |
| Vikas Sinha Owner, Officer, Director | Feb 24, 2025 | 709 | $3.05K | Feb 21, 2025 | Restricted Stock |
| Brett R. Hagen Officer | Feb 24, 2025 | 96 | $967 | Feb 21, 2025 | Restricted Stock |
| Edward Miller Officer | Jan 24, 2025 | 52 | $495 | Jan 23, 2025 | Restricted Stock |
| Brett R. Hagen Officer | Jan 24, 2025 | 36 | $341 | Jan 23, 2025 | Restricted Stock |
| Vikas Sinha Owner, Officer, Director | Jan 24, 2025 | 129 | $1.23K | Jan 23, 2025 | Restricted Stock |
| Brett R. Hagen Officer | Jan 10, 2025 | 332 | $146 | Jan 10, 2025 | Restricted Stock |
| Edward Miller Officer | Jan 10, 2025 | 409 | $180 | Jan 10, 2025 | Restricted Stock |
| Vikas Sinha Owner, Officer, Director | Jan 10, 2025 | 979 | $431 | Jan 10, 2025 | Restricted Stock |
| Brett R. Hagen Officer | Nov 19, 2024 | 554 | $302 | Nov 19, 2024 | Restricted Stock |
| Edward Miller Officer | Nov 19, 2024 | 432 | $235 | Nov 19, 2024 | Restricted Stock |
| Diana Brainard Officer, Director | Nov 19, 2024 | 8,706 | $4.76K | Nov 19, 2024 | Restricted Stock |
| Vikas Sinha Owner, Officer, Director | Nov 19, 2024 | 3,186 | $1.74K | Nov 19, 2024 | Restricted Stock |
| Edward Miller Officer | Nov 5, 2024 | 2,272 | $1.97K | Nov 5, 2024 | Restricted Stock |
See a number that looks wrong?